Effects of repeated treatment with cholecystokinin sulfated octapeptide on passive avoidance memory under chronic restraint stress in male rats

Sadeghi, Malihe; Radahmadi, Maryam; Reisi, Parham

Effects of repeated treatment with cholecystokinin sulfated octapeptide on passive avoidance memory under chronic restraint stress in male rats

Authors

¹ Department of Physiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

² Department of Physiology, School of Medicine; Applied Physiology Research Center; Biosensor Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Cholecystokinin (CCK), a peptide hormone found in the gut is the most abundant peptide neurotransmitter in the brain as well, and its effects on learning, memory, and anxiety have been shown. However, it is not clear whether this substance acts as a mediator for anxiety and stress induction or inhibits them. Hence, the purpose of this study was to evaluate the effects of CCK on memory function under stress conditions.
Materials and Methods: Male Wistar rats were divided into four groups: The control, the control-CCK, the stress, and stress-CCK. To induce stress, the rats were placed within adjustable restraint chambers for 6 h daily, for 24 days. CCK-8S (cholecystokinin sulfated octapeptide was injected before induction of stress (1.6 μg/kg, intraperitoneal) for 24 days. Passive avoidance learning test was used for evaluation of learning and memory. Rats received foot electrical shock before stress induction and CCK injection and step through latencies were evaluated 1-day after the last session of stress and treatments.
Results: Stress impaired memory significantly (P < 0.05). Although CCK per se decreased memory (P < 0.05), it prevented the memory impairments in the stress group as there was no significant difference between the control and stress-CCK groups.
Conclusion: Stress has a profound effect on cognition and CCK probably acts as a mediator for its action. Our results showed that a high concentration of CCK during stress may be helpful in alleviating the effects of stress on the brain.

Keywords

References

1.	Calabrese F, Molteni R, Riva MA. Antistress properties of antidepressant drugs and their clinical implications. Pharmacol Ther 2011;132:39-56.
2.	Howell MP, Muglia LJ. Effects of genetically altered brain glucocorticoid receptor action on behavior and adrenal axis regulation in mice. Front Neuroendocrinol 2006;27:275-84.
3.	Vazquez E, Barranco A, Dý´az A, Martý´n MJ, Gallo M, Ramý´rez M. et al. Chronic psychological stress impairs immune system as well as object and spatial memory in a water-avoidance stress (WAS) mouse model. Brain Behav Immun 2010;24:S63.
4.	Kim JJ, Rison RA, Fanselow MS. Effects of amygdala, hippocampus, and periaqueductal gray lesions on short- and long-term contextual fear. Behav Neurosci 1993;107:1093-8.
5.	Lucassen PJ, Meerlo P, Naylor AS, van Dam AM, Dayer AG, Fuchs E, et al. Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: Implications for depression and antidepressant action. Eur Neuropsychopharmacol 2010;20:1-17.
6.	Radahmadi M, Alaei H, Sharifi MR, Hosseini N. Effects of different timing of stress on corticosterone, BDNF and memory in male rats. Physiol Behav 2015;139:459-67.
7.	Wei XF, Zhang YH, Zhang LL, Xu SJ, Chen XW, Wang C, et al. CCK-8S increases the firing frequency of CCK-positive neurons and facilitates excitatory synaptic transmission in primary rat hippocampal neurons. Neurosci Lett 2013;549:34-9.
8.	Hwang CK, Kim do K, Chun HS. Cholecystokinin-8 induces brain-derived neurotrophic factor expression in noradrenergic neuronal cells. Neuropeptides 2013;47:245-50.
9.	Woltman TA, Hulce M, Reidelberger RD. Relative blood-brain barrier permeabilities of the cholecystokinin receptor antagonists devazepide and A-65186 in rats. J Pharm Pharmacol 1999;51:917-20.
10.	Abelson JL, Liberzon I. Dose response of adrenocorticotropin and cortisol to the CCK-B agonist pentagastrin. Neuropsychopharmacology 1999;21:485-94.
11.	Katsuura G, Ibii N, Matsushita A. Activation of CCK-A receptors induces elevation of plasma corticosterone in rats. Peptides 1992;13:203-5.
12.	Greenwood RS, Godar SE, Reaves TA Jr, Hayward JN. Cholecystokinin in hippocampal pathways. J Comp Neurol 1981;203:335-50.
13.	Zanoveli JM, Netto CF, Guimarães FS, Zangrossi H Jr. Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze. Peptides 2004;25:1935-41.
14.	Acosta GB. A possible interaction between CCKergic and GABAergic systems in the rat brain. Comp Biochem Physiol C Toxicol Pharmacol 2001;128:11-7.
15.	Boden PR, Woodruff GN, Pinnock RD. Pharmacology of a cholecystokinin receptor on 5-hydroxytryptamine neurones in the dorsal raphe of the rat brain. Br J Pharmacol 1991;102:635-8.
16.	Mitchell VA, Jeong HJ, Drew GM, Vaughan CW. Cholecystokinin exerts an effect via the endocannabinoid system to inhibit GABAergic transmission in midbrain periaqueductal gray. Neuropsychopharmacology 2011;36:1801-10.
17.	Siegel RA, Düker EM, Fuchs E, Pahnke U, Wuttke W. Responsiveness of mesolimbic, mesocortical, septal and hippocampal cholecystokinin and substance P neuronal systems to stress, in the male rat. Neurochem Int 1984;6:783-9.
18.	Kim H, Whang WW, Kim HT, Pyun KH, Cho SY, Hahm DH, et al. Expression of neuropeptide Y and cholecystokinin in the rat brain by chronic mild stress. Brain Res 2003;983:201-8.
19.	Voits M, Hasenöhrl RU, Huston JP, Fink H. Repeated treatment with cholecystokinin octapeptide improves maze performance in aged Fischer 344 rats. Peptides 2001;22:1325-30.
20.	Dolatabadi LK, Reisi P. Acute effect of cholecystokinin on short-term synaptic plasticity in the rat hippocampus. Res Pharm Sci 2014;9:331-6.
21.	Khan RA, Khan MR, Sahreen S. Brain antioxidant markers, cognitive performance and acetylcholinesterase activity of rats: Efficiency of Sonchus asper. Behav Brain Funct 2012;8:21.
22.	Joshi YB, Praticò D. Stress and HPA Axis Dysfunction in Alzheimer's Disease. Studies on Alzheimer's Disease. Humana Press: Springer Science+Business Media New York; 2013. Part II, p. 159-165.
23.	Hosseini N, Alaei H, Reisi P, Radahmadi M. The effect of treadmill running on memory before and after the NBM-lesion in rats. J Bodyw Mov Ther 2013;17:423-9.
24.	Ulrich-Lai YM, Figueiredo HF, Ostrander MM, Choi DC, Engeland WC, Herman JP. Chronic stress induces adrenal hyperplasia and hypertrophy in a subregion-specific manner. Am J Physiol Endocrinol Metab 2006;291:E965-73.
25.	Sandi C, Pinelo-Nava MT. Stress and memory: Behavioral effects and neurobiological mechanisms. Neural Plast 2007;2007:78970.
26.	Zhang LL, Wei XF, Zhang YH, Xu SJ, Chen XW, Wang C, et al. CCK-8S increased the filopodia and spines density in cultured hippocampal neurons of APP/PS1 and wild-type mice. Neurosci Lett 2013;542:47-52.
27.	Tirassa P, Costa N. CCK-8 induces NGF and BDNF synthesis and modulates TrkA and TrkB expression in the rat hippocampus and septum: Effects on kindling development. Neurochem Int 2007;50:130-8.
28.	Frodl T, O'Keane V. How does the brain deal with cumulative stress? A review with focus on developmental stress, HPA axis function and hippocampal structure in humans. Neurobiol Dis 2013;52:24-37.
29.	Lisowski P, Juszczak GR, Goscik J, Wieczorek M, Zwierzchowski L, Swiergiel AH. Effect of chronic mild stress on hippocampal transcriptome in mice selected for high and low stress-induced analgesia and displaying different emotional behaviors. Eur Neuropsychopharmacol 2011;21:45-62.
30.	Malendowicz LK, Spinazzi R, Majchrzak M, Nowak M, Nussdorfer GG, Ziolkowska A, et al. Effects of prolonged cholecystokinin administration on rat pituitary-adrenocortical axis: Role of the CCK receptor subtypes 1 and 2. Int J Mol Med 2003;12:903-9.
31.	Calogero AE, Nicolosi AM, Moncada ML, Coniglione F, Vicari E, Polosa P, et al. Effects of cholecystokinin octapeptide on the hypothalamic-pituitary-adrenal axis function and on vasopressin, prolactin and growth hormone release in humans. Neuroendocrinology 1993;58:71-6.
32.	Reisi P, Ghaedamini AR, Golbidi M, Shabrang M, Arabpoor Z, Rashidi B. Effect of cholecystokinin on learning and memory, neuronal proliferation and apoptosis in the rat hippocampus. Adv Biomed Res 2015; [In press, accepted: 04.01.2015].
33.	Itoh S, Takashima A, Katsuura G. Preventive effect of cholecystokinin octapeptide on scopolamine-induced memory impairment in the rat. Drug Dev Res 1988;12:63-70.
34.	Lemaire M, Böhme GA, Piot O, Roques BP, Blanchard JC. CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats. Psychopharmacology (Berl) 1994;115:435-40.
35.	Lee SY, Soltesz I. Cholecystokinin: A multi-functional molecular switch of neuronal circuits. Dev Neurobiol 2011;71:83-91.
36.	Chevaleyre V, Piskorowski R. Modulating excitation through plasticity at inhibitory synapses. Front Cell Neurosci 2014;8:93.
37.	Zucker RS. Short-term synaptic plasticity. Annu Rev Neurosci 1989;12:13-31.
38.	Misner DL, Sullivan JM. Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J Neurosci 1999;19:6795-805.
39.	Rex A, Marsden CA, Fink H. Cortical 5-HT-CCK interactions and anxiety-related behaviour of guinea-pigs: A microdialysis study. Neurosci Lett 1997;228:79-82.
40.	Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 2000;21:55-89.

Advanced Biomedical Research